Advertisement

Vestibular hyaluronic acid injection in provoked vestibulodynia patients and its effect on pain and sexual function: A preliminary report

Published:November 03, 2022DOI:https://doi.org/10.1016/j.ejogrb.2022.10.027

      Highlights

      • Hyaluronic acid injection to vulva is one of the treatment methods of vaginal dryness especially in postmenopausal women.
      • Vestibulodynia is a challenging problem for women, and it does not have a precisely defined treatment in patients without an etiology is found.
      • Women with vestibulodynia may benefit from vulvar hyaluronic acid injection.

      Abstract

      Objective

      Provoked vestibulodynia (PVD) is a challenging and distressing problem for women. The aim of this study was to examine the effect of hyaluronic acid (HA) in the management of this condition.

      Method

      This is a retrospective review of 12 women diagnosed with PVD and treated with HA (19 mg/mL) applied, point-by-point, to the vestibular region at 2 mm intervals and at a depth of 0.5 mm. Women completed a pain VAS and a Female Sexual Function Index (FSFI) before and 45 days after treatment.

      Results

      An improvement was observed both in mean FSFI scores (17.8 to 23.3; p = 0.003) and mean VAS scores (7.2 to 4.1; p = 0.002) after HA application respectively. However, on a telephone interview 3 months post treatment, five women (41.7 %) complained of recurrence of their dyspareunia.

      Conclusion

      HA is a promising management option in provoked vestibulodynia. However, further larger studies with possible alternative regimens and longer follow-up are required.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      References

        • Reed B.D.
        • Haefner H.K.
        • Sen A.
        • Gorenflo D.W.
        Vulvodynia incidence and remission rates among adult women: a 2-year follow-up study.
        Obstet Gynecol. 2008; 112: 231-237
        • Bornstein J.
        • Goldstein A.T.
        • Stockdale C.K.
        • Bergeron S.
        • Pukall C.
        • Zolnoun D.
        • et al.
        2015 ISSVD, ISSWSH and IPPS Consensus Terminology and Classification of Persistent Vulvar Pain and Vulvodynia.
        Obstet Gynecol. 2016; 127: 745-751
        • Goldstein A.T.
        • Pukall C.F.
        • Brown C.
        • Bergeron S.
        • Stein A.
        • Kellogg-Spadt S.
        Vulvodynia: Assessment and Treatment.
        J Sexual Med. 2016; 13: 572-590
        • Akopians A.L.
        • Rapkin A.J.
        Vulvodynia: The Role of Inflammation in the Etiology of Localized Provoked Pain of the Vulvar Vestibule (Vestibulodynia).
        Seminars Reprod Med. 2015; 33: 239-245
        • Arnold L.D.
        • Bachmann G.A.
        • Rosen R.
        • Rhoads G.G.
        Assessment of vulvodynia symptoms in a sample of US women: a prevalence survey with a nested case control study.
        Am J Obstet Gynecol. 2007; 196: 1281-1286
        • Bogart L.M.
        • Berry S.H.
        • Clemens J.Q.
        Symptoms of interstitial cystitis, painful bladder syndrome and similar diseases in women: a systematic review.
        J Urol. 2007; 177: 450-456
        • Peters K.
        • Girdler B.
        • Carrico D.
        • Ibrahim I.
        • Diokno A.
        Painful bladder syndrome/interstitial cystitis and vulvodynia: a clinical correlation.
        Int Urogynecol J Pelvic Floor Dysfunction. 2008; 19: 665-669
        • Landry T.
        • Bergeron S.
        • Dupuis M.J.
        • Desrochers G.
        The treatment of provoked vestibulodynia: a critical review.
        Clin J Pain. 2008; 24: 155-171
        • Rosen N.O.
        • Dawson S.J.
        • Brooks M.
        • Kellogg-Spadt S.
        Treatment of Vulvodynia: Pharmacological and Non-Pharmacological Approaches.
        Drugs. 2019; 79: 483-493
        • Morin M.
        • Carroll M.S.
        • Bergeron S.
        Systematic Review of the Effectiveness of Physical Therapy Modalities in Women With Provoked Vestibulodynia.
        Sexual Med Rev. 2017; 5: 295-322
        • Murina F.
        • Felice R.
        • Di Francesco S.
        • Oneda S.
        Vaginal diazepam plus transcutaneous electrical nerve stimulation to treat vestibulodynia: A randomized controlled trial.
        Eur J Obstet Gynecol Reprod Biol. 2018; 228: 148-153
        • Fei Z.
        • Xin X.
        • Fei H.
        • Yuechong C.
        Meta-analysis of the use of hyaluronic acid gel to prevent intrauterine adhesions after miscarriage.
        Eur J Obstet Gynecol Reprod Biol. 2020; 244: 1-4
        • Avenoso A.
        • D’Ascola A.
        • Scuruchi M.
        • Mandraffino G.
        • Calatroni A.
        • Saitta A.
        • et al.
        Hyaluronan in the experimental injury of the cartilage: biochemical action and protective effects.
        Inflamm Res. 2018; 67: 5-20
        • Bourguignon L.Y.W.
        • Earle C.
        • Shiina M.
        Activation of Matrix Hyaluronan-Mediated CD44 Signaling, Epigenetic Regulation and Chemoresistance in Head and Neck Cancer Stem Cells.
        Int J Mol Sci. 2017; 18: 1849
        • Cowman M.K.
        Hyaluronan and Hyaluronan Fragments.
        Adv Carbohydr Chem Biochem. 2017; 74: 1-59
        • Savas G.
        • Kalay N.
        • Altin P.
        • Dursun G.K.
        • Cetin M.
        • Aytekin M.
        Hyaluronan as a Promising Biomarker for Myocardial Damage.
        Tohoku J Exp Med. 2019; 248: 99-106
        • Lauer M.E.
        • Aytekin M.
        • Comhair S.A.
        • Loftis J.
        • Tian L.
        • Farver C.F.
        • et al.
        Modification of hyaluronan by heavy chains of inter-α-inhibitor in idiopathic pulmonary arterial hypertension.
        J Biol Chem. 2014; 289: 6791-6798
        • Ayteki̇n M.
        • Çaylak E.
        Hiyalüronan, tanı ve tedavideki önemi.
        Tuberk Torax. 2009; 57: 8
        • Kavasi R.-M.
        • Berdiaki A.
        • Spyridaki I.
        • Corsini E.
        • Tsatsakis A.
        • Tzanakakis G.
        • et al.
        HA metabolism in skin homeostasis and inflammatory disease.
        Food Chem Toxicol. 2017; 101: 128-138
        • Wiegel M.
        • Meston C.
        • Rosen R.
        The female sexual function index (FSFI): cross-validation and development of clinical cutoff scores.
        J Sex Marital Ther. 2005; 31: 1-20
        • Henzell H.
        • Berzins K.
        • Langford J.P.
        Provoked vestibulodynia: current perspectives.
        Int J Women's Health. 2017; 9: 631-642
        • Lynch P.J.
        Vulvodynia as a somatoform disorder.
        J Reprod Med. 2008; 53: 390-396
        • Farmer M.A.
        • Taylor A.M.
        • Bailey A.L.
        • Tuttle A.H.
        • MacIntyre L.C.
        • Milagrosa Z.E.
        • et al.
        Repeated vulvovaginal fungal infections cause persistent pain in a mouse model of vulvodynia.
        Sci Transl Med. 2011; 3
        • Turner M.L.
        • Marinoff S.C.
        Association of human papillomavirus with vulvodynia and the vulvar vestibulitis syndrome.
        J Reprod Med. 1988; 33: 533-537
        • Foster D.C.
        • Falsetta M.L.
        • Woeller C.F.
        • Pollock S.J.
        • Song K.
        • Bonham A.
        • et al.
        Site-specific mesenchymal control of inflammatory pain to yeast challenge in vulvodynia-afflicted and pain-free women.
        Pain. 2015; 156: 386-396
        • Foster D.C.
        • Piekarz K.H.
        • Murant T.I.
        • LaPoint R.
        • Haidaris C.G.
        • Phipps R.P.
        Enhanced synthesis of proinflammatory cytokines by vulvar vestibular fibroblasts: implications for vulvar vestibulitis.
        Am J Obstet Gynecol. 2007; 196: 3461-3468
        • Babula O.
        • Linhares I.M.
        • Bongiovanni A.M.
        • Ledger W.J.
        • Witkin S.S.
        Association between primary vulvar vestibulitis syndrome, defective induction of tumor necrosis factor-alpha, and carriage of the mannose-binding lectin codon 54 gene polymorphism.
        Am J Obstet Gynecol. 2008; 198: 1011-1014
        • Reissing E.D.
        • Brown C.
        • Lord M.J.
        • Binik Y.M.
        • Khalifé S.
        Pelvic floor muscle functioning in women with vulvar vestibulitis syndrome.
        J Psychosom Obstet Gynaecol. 2005; 26: 107-113
        • Mandal D.
        • Nunns D.
        • Byrne M.
        • McLelland J.
        • Rani R.
        • Cullimore J.
        • et al.
        Guidelines for the management of vulvodynia.
        Br J Dermatol. 2010; 162: 1180-1185
        • Curran S.
        • Brotto L.A.
        • Fisher H.
        • Knudson G.
        • Cohen T.
        The ACTIV study: acupuncture treatment in provoked vestibulodynia.
        J Sexual Med. 2010; 7: 981-995
        • Pukall C.
        • Kandyba K.
        • Amsel R.
        • Khalifé S.
        • Binik Y.
        Effectiveness of hypnosis for the treatment of vulvar vestibulitis syndrome: a preliminary investigation.
        J Sexual Med. 2007; 4: 417-425
        • Dworkin R.H.
        • Backonja M.
        • Rowbotham M.C.
        • Allen R.R.
        • Argoff C.R.
        • Bennett G.J.
        • et al.
        Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations.
        Arch Neurol. 2003; 60: 1524
        • Tieu K.D.
        • MacGregor J.L.
        Successful treatment of vulvodynia with botulinum toxin A.
        Arch Dermatol. 2011; 147: 251-252
        • Petersen C.D.
        • Kristensen E.
        • Lundvall L.
        • Giraldi A.
        A retrospective study of relevant diagnostic procedures in vulvodynia.
        J Reprod Med. 2009; 54: 281-287
        • Tommola P.
        • Unkila-Kallio L.
        • Paavonen J.
        Surgical treatment of vulvar vestibulitis: a review.
        Acta Obstet Gynecol Scand. 2010; 89: 1385-1395
        • Tommola P.
        • Unkila-Kallio L.
        • Paavonen J.
        Long-term follow up of posterior vestibulectomy for treating vulvar vestibulitis.
        Acta Obstet Gynecol Scand. 2011; 90: 1225-1231
        • Liang J.
        • Jiang D.
        • Noble P.W.
        Hyaluronan as a therapeutic target in human diseases.
        Adv Drug Deliv Rev. 2016; 97: 186-203
        • Sudha P.N.
        • Rose M.H.
        Beneficial effects of hyaluronic acid.
        Adv Food Nutr Res. 2014; 72: 137-176
        • Le Donne M.
        • Caruso C.
        • Mancuso A.
        • Costa G.
        • Iemmo R.
        • Pizzimenti G.
        • et al.
        The effect of vaginally administered genistein in comparison with hyaluronic acid on atrophic epithelium in postmenopause.
        Arch Gynecol Obstet. 2011; 283: 1319-1323
        • Maytin E.V.
        Hyaluronan: More than just a wrinkle filler.
        Glycobiology. 2016; 26: 553-559
        • Huynh A.
        • Priefer R.
        Hyaluronic acid applications in ophthalmology, rheumatology, and dermatology.
        Carbohydr Res. 2020; 489: 107950
        • Arslan B.
        • Gönültaş S.
        • Gökmen E.
        • Özman O.
        • Avci M.A.
        • Özdemir E.
        Outcomes of intravesical chondroitin-sulfate and combined hyaluronic-acid/chondroitin-sulfate therapy on female sexual function in bladder pain syndrome.
        Int Urogynecol J. 2019; 30: 1857-1862
        • Serati M.
        • Bogani G.
        • Di Dedda M.C.
        • Braghiroli A.
        • Uccella S.
        • Cromi A.
        • et al.
        A comparison between vaginal estrogen and vaginal hyaluronic for the treatment of dyspareunia in women using hormonal contraceptive.
        Eur J Obstet Gynecol Reprod Biol. 2015; 191: 48-50